Invesaro

Stocks Comparison

Enovis vs Inogen: revenue, profit, margins and growth compared

Enovis brought in $2.2B of revenue in fiscal 2025, Inogen $348.7M in fiscal 2025. Revenue changed by +6.7% at Enovis and +3.9% at Inogen on the year before, so Enovis grew faster. Enovis kept -52.7% of its revenue as net profit, Inogen -6.5%. Free cash flow was $19.9M at Enovis and -$13.7M at Inogen.

Side by side, latest fiscal year

ENOVINGN
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.2B$348.7M
Revenue growth+6.7%+3.9%
Net income-$1.2B-$22.7M
Net margin-52.7%-6.5%
Free cash flow$19.9M-$13.7M
Free cash flow margin0.9%-3.9%
Earnings per share (diluted)-$20.75-$0.86
Cash$36.4M$103.7M
Debt$1.3Bn/a
Price to earningsn/an/a
Market value$1.1B$142.2M
Dividend yieldn/an/a
Rank by revenue in sector#102 of 523 · Health care#213 of 523 · Health care

Over the years

Revenue
ENOV FY2018: $3.7BENOV FY2019: $3.3BENOV FY2020: $1.1BENOV FY2021: $1.4BENOV FY2022: $1.6BENOV FY2023: $1.7BENOV FY2024: $2.1BENOV FY2025: $2.2BINGN FY2018: $358.1MINGN FY2019: $361.9MINGN FY2020: $308.5MINGN FY2021: $358MINGN FY2022: $377.2MINGN FY2023: $315.7MINGN FY2024: $335.7MINGN FY2025: $348.7MFY18FY19FY20FY21FY22FY23FY24FY25
ENOV $2.2BINGN $348.7M
Net income
ENOV FY2018: $140.2MENOV FY2019: -$527.6MENOV FY2020: $42.6MENOV FY2021: $71.7MENOV FY2022: -$13.3MENOV FY2023: -$33.3MENOV FY2024: -$825.5MENOV FY2025: -$1.2BINGN FY2018: $51.8MINGN FY2019: $21MINGN FY2020: -$5.8MINGN FY2021: -$6.3MINGN FY2022: -$83.8MINGN FY2023: -$102.4MINGN FY2024: -$35.9MINGN FY2025: -$22.7MFY18FY19FY20FY21FY22FY23FY24FY25
ENOV -$1.2BINGN -$22.7M
Net margin
ENOV FY2018: 3.8%ENOV FY2019: -15.9%ENOV FY2020: 3.8%ENOV FY2021: 5.0%ENOV FY2022: -0.9%ENOV FY2023: -1.9%ENOV FY2024: -39.2%ENOV FY2025: -52.7%INGN FY2018: 14.5%INGN FY2019: 5.8%INGN FY2020: -1.9%INGN FY2021: -1.8%INGN FY2022: -22.2%INGN FY2023: -32.5%INGN FY2024: -10.7%INGN FY2025: -6.5%FY18FY19FY20FY21FY22FY23FY24FY25
ENOV -52.7%INGN -6.5%
Revenue growth
ENOV FY2019: -9.3%ENOV FY2020: -66.3%ENOV FY2021: +27.3%ENOV FY2022: +9.6%ENOV FY2023: +9.2%ENOV FY2024: +23.5%ENOV FY2025: +6.7%INGN FY2019: +1.1%INGN FY2020: -14.8%INGN FY2021: +16.1%INGN FY2022: +5.4%INGN FY2023: -16.3%INGN FY2024: +6.4%INGN FY2025: +3.9%FY19FY20FY21FY22FY23FY24FY25
ENOV +6.7%INGN +3.9%
Free cash flow
ENOV FY2018: $156.7MENOV FY2019: $5.5MENOV FY2020: $187.2MENOV FY2021: $251.9MENOV FY2022: -$161.3MENOV FY2023: $12.8MENOV FY2024: -$67.2MENOV FY2025: $19.9MINGN FY2018: $51.9MINGN FY2019: $37.5MINGN FY2020: $32.6MINGN FY2021: $18.2MINGN FY2022: -$40.9MINGN FY2023: -$8.5MINGN FY2024: $2.6MINGN FY2025: -$13.7MFY18FY19FY20FY21FY22FY23FY24FY25
ENOV $19.9MINGN -$13.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Enovis and Inogen

Which is bigger by revenue, Enovis or Inogen?

Enovis is bigger by revenue: $2.2B in fiscal 2025, against $348.7M for Inogen in fiscal 2025.

Which keeps more of its revenue as profit, Enovis or Inogen?

Enovis had a net margin of -52.7% in fiscal 2025; Inogen had -6.5% in fiscal 2025.

Which grew revenue faster, Enovis or Inogen?

In their latest fiscal years revenue changed by +6.7% at Enovis and +3.9% at Inogen.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies